Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1269.80
-78.90 (-5.85%)
< Home < Back

Dr. Reddy’s Laboratories inks MoU with LSSSDC and VIPER

Date: 07-12-2015

Dr. Reddy’s Laboratories has signed a Memorandum of Understanding (MoU) with The Life Sciences Sector Skill Development Council (LSSSDC) and Vishnu Institute of Pharmaceutical Education and Research (VIPER). The MoU is aimed at fostering market research collaboration between LSSSDC and industry partners that in turn will help align educational courses to industry requirements. The MoU will also collaborate to create pharmaceutical, biotechnology and clinical research occupation standards, as well as establish a competency matrix for job roles in the pharmaceutical sector.

The partnership is aimed at addressing the shortage of skilled and certified manpower in the industry, and will help in establishing the framework for long-term collaboration between the Council and Industry. The partnership will also help strengthen the skilled talaour pool and create standards for certification and accreditation, as per the requirements of the life sciences sector.

Dr. Reddy’s is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs.